Trials / Completed
CompletedNCT00955318
Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease
Phase 3 Study of KW-6500 (Safety Study for Long-Term Self-Administration at Home in Patients With Parkinson's Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of KW-6500 when administered as long-term subcutaneous self-injections in Parkinson's disease patients with motor response complications on levodopa therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KW-6500 | Subcutaneous injection of 1to 6 mg of KW-6500 for the OFF state |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-12-01
- Completion
- 2012-03-01
- First posted
- 2009-08-10
- Last updated
- 2017-03-15
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00955318. Inclusion in this directory is not an endorsement.